Ignite Creation Date:
2024-05-06 @ 2:20 AM
Last Modification Date:
2024-10-26 @ 11:16 AM
Study NCT ID:
NCT02013219
Status:
COMPLETED
Last Update Posted:
2020-04-21
First Post:
2013-12-11
Brief Title:
A Phase 1b Study of Atezolizumab in Combination With Erlotinib or Alectinib in Participants With Non-Small Cell Lung Cancer NSCLC
Sponsor:
Hoffmann-La Roche
Organization:
Hoffmann-La Roche
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Non-Small Cell Lung Cancer |
Keywords: